Detail of the clinical trial
| Title of the trial | Randomized comparison between two dose levels of daunorubicin and between one versus two cycles of induction therapy for adult patients with acute myeloid leukemia aged under 60 years. |
|---|---|
| EudraCT number | 2013-003191-12 |
| Protocol number | TUD-2DAUNO-058 |
| Sponsor | Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden, Germany |
| Indications | Hemato-oncology |
| Diagnosis | acute myeloid leukemia |
| Population in clinical trial |
Adults (18-65 years) Male Female Patients |
| Year of receiving the request to Institute (SÚKL) | 2015 |
| Date of approval by Institute (SÚKL) | 20.8.2015 |
| Date of approval by EC | 16.9.2015 |
| Date of initiation CT in ČR | 21.3.2016 |
| Date of ending CT in ČR | 16.10.2020 |
| Notice | |
| Sites | Fakultní nemocnice Brno, Interní hematologická a onkologická klinika, Jihlavská 20, 625 00 Brno |
cz